Body composition monitoring for people with IBD starting biologic or JAK inhibitor therapy
Official title: Body Composition Assessment and Monitoring With Bioelectrical Impedance Analysis to Predict Medical Therapy Efficacy in Inflammatory Bowel Disease (the BAMBIE Study)
Run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · NCT07162701 · Data updated 2026-11-12
This project will use bioelectrical impedance to track lean mass percentage and phase angle over one year in adults with moderate-to-severe Crohn's disease or ulcerative colitis who are starting biologic or JAK inhibitor treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Academic / other |
| Locations | 1 site (Barcelona) |
| Status | Recruiting |
| Started | July 15, 2025 |
| Main results expected | July 15, 2026 |
| Study ends | July 15, 2028 |
| Registry record updated | September 9, 2025 |
| Trial ID | NCT07162701 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–64 with a confirmed diagnosis of Crohn's disease or ulcerative colitis of more than three months' duration who have moderate-to-severe luminal activity and are about to start biologic or JAK inhibitor therapy, and who meet safety-related exclusions.
✕Probably not a fit
Patients with short bowel syndrome, major prior intestinal resections (other than ileocecal resection), active perianal disease, stricturing complications, uncontrolled diabetes, or who are not starting biologic/JAK inhibitor treatment are unlikely to benefit from this monitoring approach in the study context.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective observational study that follows adults with confirmed Crohn's disease or ulcerative colitis who begin biologic or JAK inhibitor therapy. Body composition will be measured by bioelectrical impedance analysis at baseline, 24 weeks, and 52 weeks after treatment start. Clinical activity scores, endoscopic findings, and laboratory data will be collected when available alongside the BIA measurements. All treatments follow routine clinical care and the study does not change prescribed therapy.
Why it matters
Potential benefit: If successful, the project could help clinicians detect and track muscle loss or malnutrition earlier and support better nutritional and treatment decisions for people with IBD.
How similar studies have gone: Previous observational work using bioelectrical impedance and phase angle in IBD and other chronic illnesses has shown correlations with nutritional status and outcomes, but prospective data specifically around body composition changes after starting biologics or JAK inhibitors are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any sex. * Age between 18 and 64 years. * Patients with a definitive diagnosis (\>3 months) of Crohn's disease or ulcerative colitis, according to European Crohn's and Colitis Organization criteria. * Moderate-to-severe disease luminal activity, with an indication for biologic or JAKi therapy for the induction of clinical remission. Exclusion Criteria: * Unclassified IBD. * History of intestinal resection for IBD, with the exception of ileocecal resection. * Short bowel syndrome. * Indication for medical treatment due to postsurgical recurrence. * Active perianal disease. * Indication for medical treatment due to intestinal stricture. * Previous participation in a clinical trial involving medication for IBD treatment. * Engaging in vigorous physical activity (\>6 Metabolic Equivalent of Task, METs) for more than 3 days per week. * Habitual alcohol consumption (\>1 standard drink unit/day). * Diabetes mellitus with inadequate glycemic control. * Chronic use of diuretics. * Chronic kidney disease on dialysis. * Presence of dependent edema and/or ascites. * Cardiac pacemaker bearers. * Pregnant or lactating women. * Inability to sign informed consent.
Where it's running
-
Unidad de Enfermedad Inflamatoria Intestinal
Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Antonio Giordano, MD, MSc, PhD
- Email: dr.antoniogiordano@gmail.com
- Phone: 0034 932919000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hospital-based look at infants under 6 months with acute malnutrition
This study follows hospitalized infants under 6 months with acute malnutrition to see how common it is and how they grow during treatment.
-
Collagen and omega-3 supplements in middle-aged women
This study tests whether taking collagen and omega-3s together improves joint pain, fatigue, sleep, and overall wellbeing in healthy women aged 35–65 compared with a placebo over 8 weeks.
-
Creatine or placebo to test effects on cognition, muscle strength, and body composition in middle-aged women
This study tests whether taking creatine daily for 8 weeks improves thinking, strength, fatigue, and body composition in healthy middle-aged women compared to a placebo.
-
Nutritional supplement to change body composition in women during perimenopause
A 12-week test of a supplement containing myo-inositol, berberine, cinnamon, and chromium to see if it changes body fat and other metabolic markers in women aged 38-55 compared with a placebo.
-
Preoperative Immunonutrition for bone and soft tissue sarcoma patients
This study tests whether a short course of an oral nutrition supplement before surgery can help patients with bone or soft tissue sarcomas recover better after major tumor-related surgery.
-
Dairy versus plant-based yogurt effects on weight, muscle, bones, and gut bacteria
This study will test whether eating dairy yogurt instead of a plant-based yogurt (or no yogurt) helps postmenopausal women with overweight or obesity maintain muscle and bone health, control weight, and change gut bacteria.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.